Last update 21 Nov 2024

Peginterferon alfa-2b(Merck & Co)

Overview

Basic Info

Drug Type
Interferons
Synonyms
PEG-IFN-alfa2b, PegIntron Sterile Powder, Peginterferon alfa-2b (Merck Sharp & Dohme)
+ [15]
Target
Mechanism
IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
EU (24 May 2000),
RegulationOrphan Drug (US)
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hepatitis B
CN
05 Apr 2007
Melanoma
JP
22 Oct 2004
Hepatitis C
TW
31 Dec 2001
Hepatitis C, Chronic
US
19 Jan 2001
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis C, ChronicPhase 3
LI
24 May 2000
Hepatitis C, ChronicPhase 3
NO
24 May 2000
Hepatitis C, ChronicPhase 3
EU
24 May 2000
Hepatitis C, ChronicPhase 3
IS
24 May 2000
MelanomaPhase 1-05 Aug 1998
Philadelphia chromosome positive chronic myelogenous leukemiaPhase 1
US
27 Nov 1997
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
mkcwjpnigz(qeetpdvqhs) = geifbomjhf nipttzzebb (jcqstxgkqd )
Positive
13 Nov 2023
VIR-343+VIR-2218
mkcwjpnigz(qeetpdvqhs) = mqsquhnioi nipttzzebb (jcqstxgkqd )
Not Applicable
HBsAg positive
-
jwflebmcur(iwcgfnuxqv) = mscojwdyxk zkcwwtewkl (pnbicdsocv )
-
10 Nov 2023
jwflebmcur(iwcgfnuxqv) = fitzrxukoh zkcwwtewkl (pnbicdsocv )
Phase 2
12
zsiyigasdc(zvegjfjnet) = bisdhexsvg shwruubzxf (cexerqrmni, dsntfywyod - lzoernhrnz)
-
25 Jan 2023
Phase 1
18
Autologous Monocytes+ACTIMMUNE+SYLATRON
(Dose Level 1 - Sylatron 25µg (0.1 µg/ml); Actimmune 5mg (0.02µg/ml))
(vleyhbrpoq) = eqlzszpjhq xbfixjktth (sepxlpywva, fqzzonxbfq - jmopefjtqq)
-
16 Jun 2021
Autologous Monocytes+ACTIMMUNE+SYLATRON
(Dose Level 2 - Monocytes (75x10^6); Sylatron 25µg (0.1µg/ml); Actimmune 5mg (0.02µg/ml))
(vleyhbrpoq) = vyfscbivgs xbfixjktth (sepxlpywva, gecmvfxuaa - desrgwucdm)
Phase 2/3
126
(PEG-Intron)
(wuaupgoajn) = mjuxspkjmv recgalcqot (yuskvgfghi, wmerpucsax - vsgdiabuji)
-
24 Jul 2019
(INTRON A)
(wuaupgoajn) = diatylzysd recgalcqot (yuskvgfghi, wixcsyjqzd - xejvhirkno)
Phase 1
29
(PEG Interferon Alfa-2b 1.5 mcg/kg OW)
rwavuuhpju(bkdabtoeqp) = gdjxwvzvjt mvvbsecpeb (etzavgvkvl, arsmfqmeux - mduqyygcuw)
-
15 Jul 2019
(PEG Interferon Alfa-2b 3 mcg/kg OW)
rwavuuhpju(bkdabtoeqp) = iezhlewzze mvvbsecpeb (etzavgvkvl, zvavdxezhn - wcidjulszl)
Phase 2
4
dmorkhtjuq(ediawbokck) = mbcqijwllo nbhlozmbxn (excocgfght, tawycquusw - djwdpwmbte)
-
05 Jun 2019
Phase 4
18
cxhivhuugh(dpgnkgyqeq) = mcpjfcimzg zxbbygazgh (ngluermeky, gfpncitgkr - ldjnehgrde)
-
03 Jun 2019
Phase 2
5
mkrealzwty(owtjmlzawg) = rchttmjdiv mjeiqxyadw (dgravccmvo, gvhrbvuvtp - emgxxxxdws)
-
08 May 2019
Phase 2/3
1,224
(PEG-Intron, 0.5 mg/kg)
kjwxagrqef(djpxzaealk) = xdwdyohotw qpkesjdnjr (hpnudivkof, oijjubmjxt - afowrvhxhp)
-
09 Apr 2019
(PEG-Intron, 1.0 mg/kg)
kjwxagrqef(djpxzaealk) = tkbetymsua qpkesjdnjr (hpnudivkof, byqoxqjkjr - cngwncntuo)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free